FDA Med Conference Study Raises Pharma Enforcement Risks
The U.S. Food and Drug Administration recently announced a new study on pharmaceutical companies' interactions with health care providers at exhibit booths during medical conferences.[1]...To view the full article, register now.
Already a subscriber? Click here to view full article